Zhejiang U | College of Pharmaceutical Sciences | 中文版
     
     
Feng ZHU - IDRC - Chongqing University
ABOUT THE PRINCIPAL INVESTIGATOR

Dr. Feng ZHU

Professor, Doctoral advisor, H-index & My Citations (Google Scholar)

Selected candidate of the Chinese "Recruitment Program of Global Youth Experts"
Member of Computational Chemistry Professional Committee of CCS and Task Force on Bioinformatics Professional Committee of CCF; Vice President of Chongqing Bioinformatics Society

zhufeng.ns@gmail.com (primary), zhufeng@zju.edu.cn; +86-(0)23-65678468
SPECIALTIES
Extensive knowledge and experience in computer aided drug design, drug target discovery and nature-derived drug research, which need specialties among Bioinformatics, Computational Biology, Web & Database development, server construction and System administration.

ACADEMIC APPOINTMENTS
2017.07 - Now: Professor & Doctoral Advisor in College of Pharmaceutical Sciences, Zhejiang University

2016.10 - Now: Vice President of the Chongqing Bioinformatics Society

2016.06 - Now: Committee Member of the CCF Task Force on Bioinformatics

2016.05 - Now: Editorial Board Member of the Protein & Peptide Letters

2016.02 - Now: Committee Member of the CNPHARS Precision Pharmacology

2014.09 - Now: Committee Member in CCS Computational Chemistry

2014.02 - 2017.06: Professor & Doctoral Advisor in School of Pharmaceutical Sciences, Chongqing University

2012.07 - 2014.02: PI & Doctoral Advisor in Innovative Drug Research Centre, Chongqing University

2012.01 - 2012.07: Research Fellow in Department of Pharmacy, National University of Singapore

2011.01 - 2011.12: Research Associate in Department of Pharmacy, National University of Singapore

2010.07 - 2011.01: Research Assistant in Department of Pharmacy, National University of Singapore

EDUCATIONAL QUALIFICATIONS
2006.08 - 2011.05: Doctor of Philosophy in Department of Pharmacy, National University of Singapore, Singapore

2003.08 - 2006.07: Master of Science in Key Laboratory of Applied Optics, Beijing Normal University, Beijing, P. R. China

1999.08 - 2003.07: Bachelor of Science in Department of Physics, Beijing Normal University, Beijing, P. R. China

RESEARCH GRANTS
Project on going

2017.07 - (PI): Zhejiang University "100-Plan Professor" Grant (ZJU2017070)

2016.08 - (PI): National Key Research and Development Program of China (2016YFC0902200)

2015.12 - (PI): Chongqing Special Funds for (Chemical) Drug Discovery (cstc2015zdcy-ztzx120003)

2014.03 - (PI): The Recruitment Program of Global Youth Experts (RPGYE-5-2014-CQU-ZF)


Project finished

2014.06 - (PI): Fundamental Research Funds for the Central Universities (CDJZR14 46 88 01, evaluated as "Excellent")

2013.01 - (PI): Fundamental Research Funds for the Central Universities (CQDXWL-2012-Z003, evaluated as "Excellent")

2013.01 - (PI): National Natural Science Foundation of China - The Youth Program (81202459)

2012.09 - (PI): Chongqing Natural Science Foundation (cstc2012jjA10116)

2012.08 - (PP): Tianjin Key Technology Support Program (tjkjzc2013zd01)

2012.07 - (PI): Youth 100 Talents Program of Chongqing University (0903005203176, evaluated as "Excellent")

PI: Principal Investigator; PP: Project Participant.
SELECTED PUBLICATIONS

  1. Y. H. Li, C. Y. Yu, X. X. Li, P. Zhang, J. Tang, Q. X. Yang, T. T. Fu, X. Y. Zhang, X. J. Cui, G. Tu, Y. Zhang, S. Li, F. Y. Yang, Q. Sun, C. Qin, X. Zeng, Z. Chen, Y. Z. Chen*, F. Zhu*. Therapeutic Target Database update 2018: enriched resource for facilitating bench-to-clinic research of targeted therapeutics. Nucleic Acids Research (Impact Factor: 10.162). 46(D1): D1121-D1127 (2018).
  2. F. Zhu*, X. X. Li, S. Y. Yang, Y. Z. Chen*. Clinical success of drug targets prospectively predicted by in-silico study. Trends in Pharmacological Sciences (Impact Factor: 12.797). Epub ahead of print. doi: 10.1016/j.tips.2017.12.002 (2018).
  3. B. Li, J. Tang, Q. X. Yang, S. Li, X. J. Cui, Y. H. Li, Y. Z. Chen, W. W. Xue, X. F. Li, F. Zhu*. NOREVA: normalization and evaluation of MS-based metabolomics data. Nucleic Acids Research (Impact Factor: 10.162). 45(W1): 162-170 (2017).
  4. H. Yang, C. Qin, Y. H. Li, L. Tao, J. Zhou, C. Y. Yu, F. Xu, Z. Chen, F. Zhu*, Y. Z. Chen*. Therapeutic target database update 2016: enriched resource for bench to clinical drug target and targeted pathway information. Nucleic Acids Research (Impact Factor: 10.162). 44(D1): 1069-1074 (2016).
  5. ESI Highly Cited Paper:
    • The Percentile in Subject Area shown in InCites™ was 0.87% in 2017.

  6. L. Tao, F. Zhu, C. Qin, C. Zhang, F. Xu, C. Y. Tan, Y. Y. Jiang*, Y. Z. Chen*. Nature's contribution to today's pharmacopeia. Nature Biotechnology (Impact Factor: 41.667). 32(10): 979-980 (2014).
  7. F. Zhu, Z. Shi, C. Qin, L. Tao, F. Xu, L. Zhang, X. H. Liu, J. X. Zhang, B. C. Han, P. Zhang and Y. Z. Chen*. Therapeutic target database update 2012: a resource for facilitating target-oriented drug discovery. Nucleic Acids Research (Impact Factor: 10.162). 40(D1): D1128-D1136 (2012).
  8. ESI Highly Cited Paper:
    • The Percentile in Subject Area shown in InCites™ was 0.31% in 2017.
    Highlights by Experts in Subject Area:
    • "FACULTYof1000" as "the top 2% of published articles in biology and medicine" and "a most useful resource for scientists and companies working on drug discovery and validation, drug lead discovery and optimization, and the development of multi-target drugs and drug combinations".
    • Prof. Chris Southan in his blog as "Therapeutic Target Database in PubChem".

  9. F. Zhu, C. Qin, L. Tao, X. Liu, Z. Shi, X. H. Ma, J. Jia, Y. Tan, C. Cui, J. S. Lin, C. Y. Tan, Y. Y. Jiang* and Y. Z. Chen*. Clustered patterns of species origins of nature-derived drugs and clues for future bioprospecting. PNAS (Impact Factor: 9.661). 108(31): 12943-12948 (2011).
  10. ESI Highly Cited Paper:
    • The Percentile in Subject Area shown in InCites™ was 1.91% in 2017.
    Highlights by Experts in Subject Area: Media Coverage & News Report:

  11. H. B. Rao#, F. Zhu#, G. B. Yang, Z. R. Li*, Y. Z. Chen. Update of PROFEAT: a web server for computing structural and physicochemical features of proteins and peptides from amino acid sequences. Nucleic Acids Research (Impact Factor: 10.162). 39(suppl 2): W385-390 (2011).
  12. F. Zhu, B. C. Han, P. Kumar, X. H. Liu, X. H. Ma, X. N. Wei, L. Huang, Y. F. Guo, L. Y. Han, C. J. Zheng and Y. Z. Chen*. Update of TTD: therapeutic target database. Nucleic Acids Research (Impact Factor: 10.162). 38(suppl 1): D787-D791 (2010).
  13. ESI Highly Cited Paper:
    • The Percentile in Subject Area shown in InCites™ was 2.95% in 2017.

  14. J. Jia, F. Zhu, X. H. Ma, Z. W. Cao, Y. X. Li and Y. Z. Chen*. Mechanisms of drug combinations from interaction and network perspectives. Nature Reviews Drug Discovery (Impact Factor: 57.000). 8(2): 111-128 (2009).
  15. ESI Highly Cited Paper:
    • The Percentile in Subject Area shown in InCites™ was 1.39% in 2017.
HOSTED CONFERENCE AND SYMPOSIUM

    Chairman of the Symposium IV Session -7 (metabonomics) for Asian Federation for Pharmaceutical Sciences Conference 2017. Xiamen University, Xiamen, P. R. China (2017).

    Member of the Academic Committee for The 14th National Symposium of Computer & Computational Chemistry. Nanjing University, Nanjing, P. R. China (2017).

    Member of the Academic Committee for The Second CCF Bioinformatics Conference (CBC-2017). Central South University, Changsha, P. R. China (2017).

    Chairman of the sub-conference 103 (multi-target and protein-protein interaction) for BIT’s 6th Annual International Congress of Medichem-2016 (ICM-2016) . China Pharmaceutical University, Nanjing, P. R. China. (2016).

    Vice-chairman of the 6th theme (study on drug transporter and PK/PD) for BIT’s 6th Annual International Congress of Medichem-2016 (ICM-2016) . China Pharmaceutical University, Nanjing, P. R. China. (2016).

    Chair of the Organizing Committee and the Member of the Academic Committee for The 2nd Symposium on Bioinformatics and Drug Design. Chongqing University, Chongqing, P. R. China. (2016).

    Member of the Academic Committee for The 13th National Symposium of Computer & Computational Chemistry. Sun Yat-sen University, Guangzhou, P. R. China. (2015).

    Member of the Organizing Committee for International Symposium on Natural Product Synthesis and Innovative Process Methods for Drug Manufacture. Chongqing University, Chongqing, P. R. China. (2012).

IDRB: Innovative Drug Research and Bioinformatics Group

visits since 2012
All rights are reserved by: Innovative Drug Research and Bioinformatics Group (IDRB)
College of Pharmaceutical Sciences, Zhejiang University
Hangzhou, P.R. China, 310058.
Contact number: (86-571)88208444

Last Update: